Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 31, 2014

View Archived Issues

Validation of PIM-1 inhibition as a treatment for KRas-driven NSCLC in mice

Spinal GlyT2 modulates spinal cord injury-induced spasticity in a rat model

Researchers find common genetic variant associated with cervical artery dissection

Anti-PD-L1 antibody efficacious against metastatic bladder cancer

Veliparib granted FDA orphan drug status

EB Pharma in-licenses Janssen farnesyl transferase inhibitor for HDV

FDA grants orphan drug status to OTL-38 for detecting ovarian cancer

Biotie Therapies begins phase IIa trial of SYN-120 in Parkinson's disease dementia

Dosing begins in phase I study of Kinex's KX2-361

Data presented on a novel MAPK pathway inhibitor for the treatment of colorectal cancer

Novastem treats first patient using mesenchymal and neural stem cell combination

Medtronic submits premarket approval application for SynchroMed II

Spectrum Pharmaceuticals submits NDA to FDA for Captisol-Enabled Melphalan

Corgenix Medical receives grants to support Ebola rapid test development

Determination of exosomal miRNAs as markers of multiple myeloma prognosis

Jiangsu Hengrui Medicine describes bisulfate salt of JAK inhibitor for rheumatoid arthritis

Researchers patent IL-1beta/IRAP chimeric proteins for inflammation

Janssen and Gilead amend and expand HIV single-tablet regimen development agreements

Alexion completes rolling BLA submission to the FDA for asfotase alfa

FDA approves Dyloject for pain management

EIT+ patents glycoconjugates for use as pertussis vaccines

University of Leicester patents cytolysin inhibitors

Bayer Schering Pharma describes TTK inhibitors

Nanjing Sanhome Pharmaceutical prepares anti-HCV nucleosides

VEGFR-2 inhibitors reported in Kala Pharmaceuticals patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...